Date | Insider | Price | Amount |
---|---|---|---|
8-17-2023 Insider Buy |
Gregory Scott Duncan CHIEF EXECUTIVE OFFICER |
$1.25 CAGR » |
$31,245.00 25,000 shares |
5-23-2022 Insider Buy |
Angela Walsh SVP OF FINANCE |
$4.58 CAGR » |
$9,150.00 2,000 shares |
5-18-2022 Insider Buy |
Richard James Whitley |
$4.53 CAGR » |
$2,262.50 500 shares |
5-18-2022 Insider Buy |
William Pridgen |
$4.50 CAGR » |
$1,084.50 241 shares |
5-17-2022 Insider Buy |
William Pridgen |
$4.38 CAGR » |
$58,913.69 13,450 shares |
3-29-2022 Insider Buy |
William Pridgen |
$4.94 CAGR » |
$2,964.48 600 shares |
3-23-2022 Insider Buy |
William Pridgen |
$5.46 CAGR » |
$12,001.55 2,197 shares |
1-27-2022 Insider Buy |
William Pridgen |
$5.98 CAGR » |
$24,997.65 4,180 shares |
1-7-2022 Insider Buy |
Rosa Abel De La |
$5.90 CAGR » |
$23,584.00 4,000 shares |
1-6-2022 Insider Buy |
Richard James Whitley |
$5.72 CAGR » |
$10,296.00 1,800 shares |
1-4-2022 Insider Buy |
David R. Keefer |
$5.79 CAGR » |
$28,975.00 5,000 shares |
12-21-2021 Insider Buy |
William Pridgen |
$5.66 CAGR » |
$49,997.01 8,827 shares |
7-7-2021 Insider Buy |
William Pridgen |
$6.32 CAGR » |
$5,950.61 942 shares |
4-6-2021 Insider Buy |
Gregory Scott Duncan Chief Executive Officer |
$6.36 CAGR » |
$2,428.60 382 shares |
4-5-2021 Insider Buy |
Gregory Scott Duncan Chief Executive Officer |
$6.17 CAGR » |
$96,757.07 15,675 shares |
1-29-2021 Insider Buy |
William Pridgen Director |
$7.47 CAGR » |
$26,145.00 3,500 shares |
1-28-2021 Insider Buy |
Angela Walsh VP of Finance |
$7.30 CAGR » |
$7,300.00 1,000 shares |
12-17-2020 Insider Buy |
William Pridgen Director |
$11.98 CAGR » |
$17,970.00 1,500 shares |
Also See: Institutional Holders of VIRI
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 08/18/2023 | |
End date: | 05/06/2024 | |
Start price/share: | $1.25 | |
End price/share: | $0.41 | |
Dividends collected/share: | $0.00 | |
Total return: | -67.20% | |
Annualized Gain: | -93.62% | |
Starting investment: | $10,000.00 | |
Ending investment: | $3,280.00 | |
Years: | 0.72 |
Virios Therapeutics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Virios Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding VIRI
Free VIRI Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Virios Therapeutics Insider Buying occurred are:
HOOKIPA Pharma Insider Buying |